Doctors Note Logo

Published on: 10/26/2026

Venlafaxine Side Effects: Blood Pressure, Sweating and Discontinuation

Venlafaxine (Effexor) can raise blood pressure in a dose-dependent way, trigger heavy sweating and night sweats, and cause a notably difficult discontinuation syndrome with dizziness, "brain zaps," nausea, and irritability when doses are missed or stopped abruptly. Higher daily doses, typically above 150 mg, carry the greatest hypertension risk, which is why periodic blood pressure monitoring and a slow, supervised taper matter so much. Sweating may improve over time or respond to dose adjustments and other strategies, and timing, formulation, and individual health history all change how these effects show up. There are several important factors to consider before assuming your symptoms are harmless or unrelated, so see below to understand more.

If you are noticing new sweating, blood pressure changes, or withdrawal-like symptoms and are unsure whether they stem from your medication, something else, or both, a free, instant, online symptom check can help you sort out likely causes in minutes and show you which next steps deserve urgent attention versus a routine conversation with your prescriber.

Last reviewed for medical accuracy: 10/22/2026

answer background

Concerned about your symptoms?

Explanation

Side Effects of Venlafaxine: Blood Pressure, Sweating and Discontinuation

Venlafaxine (brand name Effexor) is a serotonin-norepinephrine reuptake inhibitor (SNRI) commonly prescribed for depression, generalized anxiety disorder and other mood conditions. While many users benefit from relief of symptoms, it’s important to understand the potential side effects of venlafaxine—especially changes in blood pressure, increased sweating and withdrawal symptoms when stopping the drug.

How Venlafaxine Works

Venlafaxine boosts levels of serotonin and norepinephrine in the brain, which can improve mood, concentration and energy. It typically takes 4–6 weeks to see full benefit. Doses range from 37.5 mg up to 225 mg daily, depending on the condition treated and individual response.

Common Side Effects of Venlafaxine

Most people tolerate venlafaxine well, but some side effects occur in 10% or more of users:

  • Nausea or upset stomach
  • Headache
  • Dizziness
  • Dry mouth
  • Insomnia or sleepiness
  • Loss of appetite
  • Constipation

These often improve over days to weeks. If they persist or worsen, talk with your doctor about adjusting your dose or switching medications.

Blood Pressure Changes

One of the well-documented side effects of venlafaxine is an increase in blood pressure, especially at higher doses.

Why It Happens

  • Norepinephrine boost can constrict blood vessels
  • Dose-related: more common at doses ≥ 150 mg/day

What to Watch For

  • A sustained rise in systolic blood pressure of 5–10 mm Hg
  • Hypertension symptoms: headache, blurred vision, chest pain

Recommendations

  • Check your blood pressure before starting treatment
  • Monitor at 1–2 week intervals after dose increases
  • If readings exceed 140/90 mm Hg, notify your doctor
  • Lifestyle measures: reduce salt intake, stay active, manage stress
  • In some cases, a low-dose blood pressure medication may be added

Excessive Sweating (Hyperhidrosis)

Sweating is another commonly reported side effect of venlafaxine.

How Often It Occurs

  • Seen in up to 10–15% of users
  • Usually begins within the first few weeks

Typical Pattern

  • More pronounced at night or during exercise
  • Can be mild (damp clothing) to severe (soaked sheets, drenching)

Management Tips

  • Wear moisture-wicking fabrics
  • Shower before bedtime; change sheets regularly
  • Avoid spicy foods, caffeine and hot environments
  • Use clinical-strength antiperspirants
  • If sweating interferes with daily life, discuss dose reduction or switching medications

Discontinuation Syndrome

Stopping venlafaxine abruptly can trigger a “discontinuation syndrome” that may be more intense than with other antidepressants.

Common Withdrawal Symptoms

  • Dizziness or “brain zaps” (electric shock sensations)
  • Insomnia or vivid dreams
  • Irritability, anxiety or mood swings
  • Flu-like aches, nausea or sweating

Risk Factors

  • Short half-life: venlafaxine leaves the body faster than many other SSRIs/SNRIs
  • Higher daily doses
  • Abrupt dose reduction

Safe Tapering Strategies

  • Gradual dose reduction over at least 4–6 weeks
  • Consider switching to an extended-release form before tapering
  • Monitor closely for emerging withdrawal symptoms

When to Seek Help

  • Severe dizziness that impairs daily activities
  • Persistent nausea or vomiting
  • Worsening mood or suicidal thoughts

Other Less Common but Serious Side Effects

While rare, be aware of:

  • Serotonin syndrome (confusion, rapid heart rate, high fever) when combined with other serotonergic drugs
  • Increased bleeding risk if taking blood thinners or NSAIDs
  • Eye pressure increase (glaucoma risk)
  • Seizures in those with seizure disorders

If you notice any alarming signs—high fever, rash, severe headache, vision changes, chest pain—seek medical attention right away.

Tips for Managing and Monitoring Side Effects

  1. Keep a Symptom Diary
    Track any new or worsening symptoms, noting date, dose and severity.
  2. Stay Hydrated and Eat Balanced Meals
    Proper nutrition can reduce nausea and help stabilize blood pressure.
  3. Regular Check-Ins with Your Doctor
    Review side effects, mood and blood pressure at scheduled visits.
  4. Lifestyle Adjustments
    Exercise, stress-reduction techniques and good sleep habits often ease side effects.
  5. Use a Symptom Checker
    Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help you decide if you should seek medical advice.

When to Talk to a Doctor

  • New or worsening high blood pressure
  • Severe anxiety or panic attacks
  • Intense withdrawal symptoms during tapering
  • Any life-threatening or serious concerns

Your healthcare provider can adjust your dose, recommend treatments for side effects, or switch you to a different antidepressant if needed. Never stop venlafaxine suddenly without medical guidance—doing so increases the risk of withdrawal symptoms.


This overview of the side effects of venlafaxine is based on credible sources, including prescribing information and clinical guidelines. Always speak to a doctor about any concerns or symptoms that could be serious—they can give you personalized advice and ensure your treatment is safe and effective.

(References)

  • * Horsmans Y, De Clercq M, Sempoux C. Venlafaxine-associated hepatitis. Ann Intern Med. 1999 Jun 1;130(11):944. doi: 10.7326/0003-4819-130-11-199906010-00014. PMID: 10375350.

  • * Sheehan DV. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder. J Clin Psychiatry. 1999;60 Suppl 22:23-8. PMID: 10634352.

  • * Cardona X, Avila A, Castellanos P. Venlafaxine-associated hepatitis. Ann Intern Med. 2000 Mar 7;132(5):417. doi: 10.7326/0003-4819-132-5-200003070-00016. PMID: 10691596.

  • * Linnebur SA, Saseen JJ, Pace WD. Venlafaxine-associated vaginal bleeding. Pharmacotherapy. 2002 May;22(5):652-5. doi: 10.1592/phco.22.8.652.33219. PMID: 12013367.

  • * Claassen JA, Gelissen HP. The serotonin syndrome. N Engl J Med. 2005 Jun 9;352(23):2454-6; author reply 2454-6. PMID: 15948274.

  • * Arroyo VC, Hallal H, Agudo JL, Aniorte JP. [Venlafaxine-induced cholestatic hepatitis]. Gastroenterol Hepatol. 2009 May;32(5):382-3. doi: 10.1016/j.gastrohep.2008.11.012. Epub 2009 May 13. PMID: 19442411.

  • * Ceylan ME, Evrensel A. Venlafaxine induced akathisia: a case report. Trends Psychiatry Psychother. 2016 Apr-Jun;38(2):117. doi: 10.1590/2237-6089-2015-0084. PMID: 27409139.

  • * Smischney NJ, Pollard EM, Nookala AU, Olatoye OO. Serotonin Syndrome in the Perioperative Setting. Am J Case Rep. 2018 Jul 16;19:833-835. doi: 10.12659/AJCR.909497. Epub 2018 Jul 16. PMID: 30008467; PMCID: PMC6061453.

  • * Özden HC, Gürel ŞC. Neuroleptic Malignant Syndrome with Low-dose Quetiapine After Venlafaxine Withdrawal: A Case Report. Turk Psikiyatri Derg. 2025;36:26. doi: 10.5080/u27497. Epub 2024 Sep 19. PMID: 41070489; PMCID: PMC11987542.

  • * Terao I. Clinical relevance of venlafaxine ER for generalized anxiety disorder. Psychiatry Clin Neurosci. 2026 Apr;80(4):358. doi: 10.1111/pcn.13924. Epub 2025 Nov 19. PMID: 41255146.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.